Article Details

AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says

Retrieved on: 2023-01-05 20:29:35

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says. View article details on hiswai:

Excerpt

While risk sharing is still an essential part of AZN's strategy, the company's acquisition of Alexion and durable growth of Oncology should ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up